How many investments has Percipient Capital made?

Percipient Capital has 7 tracked investments.

What stage does Percipient Capital invest at?

Percipient Capital invests at the Seed, Series A, Series B, Series C, Late Stage stages.

What is Percipient Capital's typical check size?

Percipient Capital typically writes checks of $1.3M – $6.3M.

Where is Percipient Capital located?

Percipient Capital is headquartered in London, GB.

Who does Percipient Capital co-invest with?

Percipient Capital most often shares deals with ALSA Ventures, Calculus Capital Ltd., Oxford, among 4 tracked co-investors.

Percipient Capital

Private equity

London · Seed–Late Stage · 3 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Percipient Capital

846 people in our graph share verified history with the Percipient Capital team — schools, employers, funds. One of them is your warm intro.

Niki Pezeshkiunlockedknows Jason Gould · together at Goldman Sachs (overlapped)

×9knows the team · via Goldman Sachs

×2knows the team · via University of Houston

✨ Fox Verdict

Investment thesis

Percipient Capital provides private equity and venture capital to small and medium-sized businesses. Its focus is twofold: helping entrepreneurs grow existing businesses and backing management teams to buy the businesses they run but do not own. The firm manages funds on behalf of high net worth individuals, family offices, and institutional investors. It personally invests in every business it backs and charges investors based on success, aiming to align interests with both portfolio companies and investors while building shareholder value. Over 15 years the team has supported more than 45 companies.

Invests inAdvanced Manufacturing Biotech Enterprise Software Medical Devices SaaSSector AgnosticLondon United Kingdom

Source: firm website, verified Aug 3, 2026.

Stage

Seed–Late Stage

Check

$1.3M – $6.3M

London, GB

Instruments

Equity

Founded

2010

Tracked investments

Team · 3 people

from public directories

Ed Farquhar· Director· Londonin

Co-founder of Percipient and a founder and former director of Numis Securities, where he led the Equity Capital Markets team. With 15 years of City experience focused on SMEs, he has worked on IPOs and secondary financings and has sourced and completed private equity transactions, serving on several company boards.

e•••@percipientcapital.comreveal

Jason Gould· Director· Northamptonshirein

A co-founder of Percipient with over 20 years in venture capital and private equity, previously a director at HSBC Ventures and a Fund Principal at the South East Growth Fund. He has led over 75 investment rounds across more than 40 companies spanning biotech, software, manufacturing, distribution and business services, and holds various non-executive director and chairman roles.

j•••@percipientcapital.comreveal

James Bingham· Associate

James Bingham has nine years of experience in corporate finance, advisory, and family office work across the UK and Asia, and has been with Percipient Capital since May 2019, working on new and follow-on investments. He studied Economics and Business Management at Newcastle University.

j•••@percipientcapital.comreveal

What they invest in

from 2 of 7 portfolio companies

Biotech ×1Cloud Computing ×1Enterprise Software ×1Fintech ×1Healthtech ×1Medical Devices ×1SaaS ×1

HQs:United Kingdom×2

Investments · 7 tracked

founders shown can be your intro path

Drinks Warehouse UK

Evoque

MyWorkpapersmyworkpapers.com in 𝕏

BrightWorkpapers helps accounting firms modernize their operations by replacing outdated processes with more efficient digital systems to improve productivity.

Cloud ComputingEnterprise SoftwareFintechSaaSUK, GB

Oxford BioTherapeuticsoxfordbiotherapeutics.com

Oxford BioTherapeutics is a clinical-stage oncology company developing antibody-based therapies for cancer treatment.

BiotechHealthtechMedical DevicesOxford, GB

Co-investorsCalculus Capital Ltd.Oxford Perscitus LLP

Redkite

Financial surveillance software business founded by two former JP Morgan executives; sold in October 2012.

River Marketing

Thames Cryogenics

Principals & officers · per Companies House

what is this? ⓘ

Edward Peter Henry Farquhar

Director · British · since 2016

Jason Lee Gould

Director · British · since 2016

Ownership & control

Gkf Wealth Management Limited — 75–100% of shares, 75–100% of voting rights

Frequently asked questions

How many investments has Percipient Capital made?: Percipient Capital has 7 tracked investments.
What stage does Percipient Capital invest at?: Percipient Capital invests at the Seed, Series A, Series B, Series C, Late Stage stages.
What is Percipient Capital's typical check size?: Percipient Capital typically writes checks of $1.3M – $6.3M.
What sectors does Percipient Capital focus on?: Percipient Capital focuses on Advanced Manufacturing, Biotech, Enterprise Software, Medical Devices, SaaS, Sector Agnostic.
Where is Percipient Capital located?: Percipient Capital is headquartered in London, GB.
Who does Percipient Capital co-invest with?: Percipient Capital most often shares deals with ALSA Ventures, Calculus Capital Ltd., Oxford, among 4 tracked co-investors.

Images

Similar investors

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

$10M – $50M

Khosla Ventures

Khosla Ventures is a venture capital firm founded by Vinod Khosla.

IDG Capital is a multi-strategy investment platform founded in 1993 that supports entrepreneurs across the full business lifecycle, bridging East and West with a global presence and over 300 professionals.

$3M – $200M

SMBC Venture Capital

SMBC Venture Capital is a Japanese venture capital firm and a member of Sumitomo Mitsui Financial Group (SMBC Group), with over 20 years of investing experience. It leverages the group's network of auditors, securities firms, and other investors to support startups.

$2.3M – $269M